# HYRIMOZ

NDC: 83457-101
Generic name: adalimumab-adaz
Labeler / Manufacturer: Cordavis Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20230921

FDA application: BLA761071

## Active ingredients

- ADALIMUMAB: 40 mg/.4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"83457-101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=83457-101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3e303a4a-980b-4f2a-9d03-786928758637